Chongqing Pharscin Pharmaceutical (002907.SZ) has completed the domestic production drug registration for three products.
Huarson Pharmaceuticals (002907.SZ) announcement, the company recently obtained information from the website of the China Food and Drug Administration that the company's...
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently obtained information from the website of the National Medical Products Administration that three of the company's products have completed the domestic production drug filing (application for drug instructions suitability for the elderly) and the filing information has been publicly posted on the website of the National Medical Products Administration. The related products are: Ba Wei Qi Long Granules, Teng Xie Ning Granules, and Gan Ju Bing Mei Pian.
Related Articles
Yonz Technology (603381.SH): Junlianxiangdao and Junlian Jia Mao plan to reduce their combined holding of company shares by no more than 3%.
China Securities Co., Ltd.: The Shanghai Stock Exchange breaks through 4000 points, how to respond at the year end?
CCOE(08286): Liquidation request hearing postponed to December 3rd.
Yonz Technology (603381.SH): Junlianxiangdao and Junlian Jia Mao plan to reduce their combined holding of company shares by no more than 3%.
China Securities Co., Ltd.: The Shanghai Stock Exchange breaks through 4000 points, how to respond at the year end?
CCOE(08286): Liquidation request hearing postponed to December 3rd.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
